Article ID Journal Published Year Pages File Type
7503790 Drug and Alcohol Dependence 2016 36 Pages PDF
Abstract
These results show that RewP amplitude in response to rewarded trials tracks state anhedonia severity in iCUD. We argue that this association is perhaps driven by the activity in the dopaminergic mesocorticolimbic reward pathway that may underlie anhedonia symptomology as well as modulate RewP amplitude.
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Authors
, , , ,